|
| Home : Stem Cell Therapeutics Completes $33 Million Private Placement |
|
Dec 14
2013 |
Stem Cell Therapeutics Completes $33 Million Private Placement |
|
TORONTO, ONTARIO--(Marketwired - Dec. 13, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell- related therapeutics, is pleased to announce that it has raised gross proceeds of $33 million through a private placement of units. The financing proceeds will be used to advance the Company's CD47 cancer stem cell program through IND-enabling studies, manufacturing and phase 1 clinical trials. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=1862413&sourceType=3 |
| |
|
Related News
|
» Digital Shelf Space Announces Closing of Second Stage of $500,000 Financing
» Another Shot of Wintry Weather Headed to Northeast
|
|
|
